Universal Coronavirus mRNA Vaccine (UCV-mRNA)
Infectious Disease/Vaccines
A functionally biosimilar mRNA prophylactic or therapeutic vaccine, or vaccine booster, to enable sustained immunity to current and future SARS-CoV-2 variants.
Project Team
PA
Peter A. Jensen
Institutions
NB
Normax Biomed Limited
IE
Project Status
Clinical Stage
Preclinical
Patent Status
Patent not filed
Funding Opportunity
Opportunity type
Funding requested
$500,000
Funding allocated
$0
Background
The COVID-19 pandemic cost 20 million lives and $28 Trillion dollars. https://normaxbiomed.com/
Project Details
A functionally biosimilar mRNA prophylactic or therapeutic vaccine, or vaccine booster, to enable sustained immunity to current and future SARS-CoV-2 variants. https://normaxbiomed.com/
Project Timeline
Universal Coronavirus mRNA Vaccine (UCV-mRNA)
Required Funding$500,000
Statusongoing
Duration6 MonthsUCV-mRNA vaccine design, testing and pre-clinical validation.
Project Team
PA
Peter A. Jensen
Institutions
NB
Normax Biomed Limited
IE
Project Status
Clinical Stage
Preclinical
Patent Status
Patent not filed
Funding Opportunity
Opportunity type
Funding requested
$500,000
Funding allocated
$0